Treat and Extend Analysis Trial With Aflibercept in Wet-AMD

NCT04113538 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Wet Age-related Macular Degeneration

Interventions

DRUG: Aflibercept

Sponsor

Michel Giunta

Collaborators

[object Object]